Antivirals Flashcards

1
Q

4 targets for antivirals in HIV drugs

A

entry, reverse transcriptase, integrase, protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mechanism of action for NRTI’s

A

viral DNA chain termination via inhibition of reverse transcriptase enzyme. pose as pieces of DNA and get picked up and stop the enzyme!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NRTI class side effects

A

lactic acidosis (much less common with newer agents). GI side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NRTI agents

A

zidovudine, stavudine, didanosine, tenofovir, abacavir, zalcitabine, lamivudine, emtricitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NNRTI mechanism of action

A

bind directly to reverse transcriptase and inhibit its actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NNRTI agents

A

efavirenz, nevirapine, etravirine, rilpivirine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NNRTI side effects

A

cause a rash. may cause CNS effects like vivid dreams, drowsiness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

protease inhibitor agents

A

norvir, lexiva, kaletra, reyataz, prezista

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

protease inhibitor mechanism of action

A

bind within active pocket of protease, inhibiting binding of the virus. without protease cleavage, virus cannot cause infection!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is curious about ritonavir?

A

ritonavir at low doses enhances blood levels of other protease inhibitors! give together to increase clinical effectiveness and require less doses of other drugs!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

protease inhibitor class toxicities

A

GI: N/V, diarrhea
Metabolic: dyslipidemia, hyperglycemia, lipodystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

enfuvirtide mechanism of action

A

messes with GP41, which makes the connection for CD4 binding. messes with HIV attachment and fusing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

enfuvirtide adverse effects

A

local injection sight reaction. increased rate of bacterial pneumonia. hypersensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CCR5 antagonists

A

HIV often uses CCR5 as a co-receptor necessary to enter T cells. Maraviroc is only agent. Only drug that acts on the host cell, all others act on HIV molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CCR5 adverse effects

A

hepatotoxicity. cough, fever, URI, rash, musculoskeletal, ab pain, dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

integrase inhibitor agents

A

raltegravir, elvitegravir, dolutegravir.

17
Q

integrase inhibitor mechanism of action

A

inhibit viral enzyme integrase. necessary for insertion of viral DNA into human genomic DNA

18
Q

integrase inhibitor adverse effects

A

generally few adverse effects. commonly seen: Nausea, headache, diarrhea, pyrexia. myopathy seen sometimes

19
Q

basics of HAART

A

use at least 3 active agents representative of 2 classes of agents

20
Q

goals of HAART

A

suppress viral load, restore immune function, improve quality of life, reduce HIV related morbidity and mortality, minimize risk for antiretroviral resistance

21
Q

NS5B polymerase inhibitors agents

A

sofosbuvir, paritaprevir

22
Q

NS5B polymerase inhibitors mechanism of action

A

inhibitor of Hep C NS5B RNA dependent RNA polymerase. competes with natural viral nucleotides to cause chain termination

23
Q

NS5A inhibitor agents

A

ledipasvir, daclatasvir, ombitasvir

24
Q

NS5A inhibitor mechanism of action

A

inhibits hep C NS5A, a viral phosphoprotein required for viral replication.

25
NS3/4A protease inhibitor agents
simeprevir, boceprevir, telaprevir
26
NS3/4A protease inhibitor mechanism of action
prevent viral maturation through the inhibition of protein synthesis
27
acyclovir mechanism of action
after phosphorylation by cellular enzymes, acyclovir triphosphate competes with DNA analogues to cause viral DNA chain termination. needs viral thymidine kinase to become active
28
other drugs like acyclovir
valacyclovir, peniciclovir, famciclovir
29
acyclovir toxicity concerns
CNS: malaise, headache, confusion. N/V, diarrhea. renal dysfunction seen in high doses of IV therapy due to drug crystallizing in kidneys
30
ganciclovir
active mainly against Cytomegalovirus. (CMV). Use the prodrug when you need to give orally, as the actual drug has bad bioavailability. biggest side effect is myelosuppression
31
foscarnet
inhibitory effect on herpesvirus and HIV. directly inhibits herpesvirus DNA polymerase or HIV reverse transcriptase.
32
foscarnet tox issues
nephrotox, electrolyte/metabolic abnormalities, CNS side effects, myelosuppression. only used when people have resistance to other herpes drugs
33
neuraminidase inhibitors
oseltamivir, zanamivir, peramivir. inhibit enzyme critical in penetration of respiratory tract mucus and in the release of virus from infected cells. active against flu A and B
34
neuraminidase inhibitor adverse effects
N/V, diarrhea. neuropsychiatric events reported. zanamavir can cause bronchospasm. peramivir is used only in critically ill